Repligen (RGEN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.54
- EPS estimate
- $0.45
- EPS surprise
- +20.72%
- Revenue surprise
- +1.26%
- Revenue
- $204.1M
- Revenue estimate
- $201.6M
- Reported
- Jul 28, 2026
Repligen reported Q2 2026 results on July 28, 2026. Earnings per share were $0.54, ahead of the $0.45 estimate by 20.72%. Revenue was $204.1 million, above the $201.6 million consensus. Compared with Q2 2025, EPS rose about 46% from $0.37 and revenue rose about 12% from $182.4 million.
The longer record shows a dip and a recovery. Annual EPS fell from $3.28 in 2022 to $1.73 in 2023 and $1.48 in 2024, then rose to $1.71 in 2025. Revenue followed a similar path, from about $801 million in 2022 to $628 million in 2024 and $738 million in 2025. The first half of 2026 adds up to $1.02 per share, about 34% more than the $0.76 a year earlier. Quarterly revenue is now back near the Q2 2022 high of $207.6 million, but EPS remains below the $0.92 peak of Q1 2022. Over the last 20 quarters, Repligen beat the EPS estimate 18 times, including each of the last four.
Repligen reported Q3 between October 28 and November 12 in each of the past five years. That points to late October or early November 2026 for the next report, which will show whether the year-over-year growth of recent quarters holds.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 28, 2026 | $0.45 | $0.54 | +20.72% | $204.1M | SEC |
| Q1 2026 | May 5, 2026 | $0.38 | $0.48 | +25.03% | $194.3M | SEC |
| Q4 2025 | Feb 24, 2026 | $0.44 | $0.49 | +11.06% | $197.9M | SEC |
| Q3 2025 | Oct 28, 2025 | $0.42 | $0.46 | +9.11% | $188.8M | SEC |
| Q2 2025 | Jul 29, 2025 | $0.39 | $0.37 | −4.69% | $182.4M | SEC |
| Q1 2025 | Apr 29, 2025 | $0.35 | $0.39 | +12.68% | $169.2M | SEC |
| Q4 2024 | Feb 20, 2025 | $0.41 | $0.44 | +7.24% | $167.5M | SEC |
| Q3 2024 | Nov 12, 2024 | $0.34 | $0.43 | +28.21% | $154.9M | SEC |
| Q2 2024 | Jul 30, 2024 | $0.33 | $0.33 | +1.20% | $154.1M | SEC |
| Q1 2024 | May 1, 2024 | $0.30 | $0.28 | −6.98% | $151.3M | SEC |
| Q4 2023 | Feb 21, 2024 | $0.33 | $0.33 | +1.29% | $155.7M | SEC |
| Q3 2023 | Oct 31, 2023 | $0.16 | $0.23 | +39.48% | $141.2M | SEC |
| Q2 2023 | Aug 2, 2023 | $0.48 | $0.53 | +11.56% | $159.2M | SEC |
| Q1 2023 | May 2, 2023 | $0.59 | $0.64 | +8.79% | $182.7M | SEC |
| Q4 2022 | Feb 22, 2023 | $0.58 | $0.68 | +17.93% | $186.8M | SEC |
| Q3 2022 | Nov 1, 2022 | $0.68 | $0.77 | +13.25% | $200.7M | SEC |
| Q2 2022 | Aug 2, 2022 | $0.71 | $0.91 | +27.49% | $207.6M | SEC |
| Q1 2022 | Apr 27, 2022 | $0.72 | $0.92 | +27.78% | $206.4M | SEC |
| Q4 2021 | Feb 17, 2022 | $0.65 | $0.81 | +24.85% | $186.5M | SEC |
| Q3 2021 | Oct 28, 2021 | $0.64 | $0.78 | +22.47% | $178.2M | SEC |
Quarterly revenue
Frequently asked questions
When did Repligen (RGEN) last report earnings?
Repligen last reported on Jul 28, 2026, covering fiscal Q2 2026.
Did RGEN beat earnings estimates?
Yes. Repligen reported EPS of $0.54 for Q2 2026 against a $0.45 estimate — a 20.72% beat.
How much revenue did RGEN report last quarter?
Repligen reported $204.1M in revenue for Q2 2026, against a consensus estimate of $201.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.